Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial

Heikki Joensuu; Pirkko-Liisa Kellokumpu-Lehtinen; Riikka Huovinen; Arja Jukkola; Minna Tanner; Johan Ahlgren; Paivi Auvinen; Outi Lahdenperä; Kenneth Villman; Paul Nyandoto; Greger Nilsson; Paula Poikonen-Saksela; Vesa Kataja; Petri Bono; Jouni Junnila; Henrik Lindman

doi:10.1200/JCO.21.02054

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial

Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola, Minna Tanner, Johan Ahlgren, Paivi Auvinen, Outi Lahdenperä, Kenneth Villman, Paul Nyandoto, Greger Nilsson, Paula Poikonen-Saksela, Vesa Kataja, Petri Bono, Jouni Junnila, Henrik Lindman

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Journal of Clinical Oncology
Volym	40
Nummer	10
Sidor (från-till)	1051-+
Antal sidor	10
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.21.02054
Status	Publicerad - 1 apr. 2022
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1200/JCO.21.02054

Citera det här

Joensuu, H., Kellokumpu-Lehtinen, P-L., Huovinen, R., Jukkola, A., Tanner, M., Ahlgren, J., Auvinen, P., Lahdenperä, O., Villman, K., Nyandoto, P., Nilsson, G., Poikonen-Saksela, P., Kataja, V., Bono, P., Junnila, J., & Lindman, H. (2022). Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial. Journal of Clinical Oncology, 40(10), 1051-+. https://doi.org/10.1200/JCO.21.02054

@article{f750e638ec5d4ca0b73333b2cd0c4ebb,

title = "Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial",

keywords = "DOSE-DENSE CHEMOTHERAPY, PHASE-III TRIAL, NEOADJUVANT CHEMOTHERAPY, CYCLOPHOSPHAMIDE, DOCETAXEL, EPIRUBICIN, THERAPY, METAANALYSIS, ENHANCEMENT, COMBINATION, 3122 Cancers",

author = "Heikki Joensuu and Pirkko-Liisa Kellokumpu-Lehtinen and Riikka Huovinen and Arja Jukkola and Minna Tanner and Johan Ahlgren and Paivi Auvinen and Outi Lahdenper{\"a} and Kenneth Villman and Paul Nyandoto and Greger Nilsson and Paula Poikonen-Saksela and Vesa Kataja and Petri Bono and Jouni Junnila and Henrik Lindman",

year = "2022",

month = apr,

day = "1",

doi = "10.1200/JCO.21.02054",

language = "English",

volume = "40",

pages = "1051--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "10",

}

Joensuu, H, Kellokumpu-Lehtinen, P-L, Huovinen, R, Jukkola, A, Tanner, M, Ahlgren, J, Auvinen, P, Lahdenperä, O, Villman, K, Nyandoto, P, Nilsson, G, Poikonen-Saksela, P, Kataja, V, Bono, P, Junnila, J & Lindman, H 2022, 'Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial', Journal of Clinical Oncology, vol. 40, nr. 10, s. 1051-+. https://doi.org/10.1200/JCO.21.02054

TY - JOUR

T1 - Adjuvant Capecitabine for Early Breast Cancer

T2 - 15-Year Overall Survival Results From a Randomized Trial

AU - Joensuu, Heikki

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

AU - Huovinen, Riikka

AU - Jukkola, Arja

AU - Tanner, Minna

AU - Ahlgren, Johan

AU - Auvinen, Paivi

AU - Lahdenperä, Outi

AU - Villman, Kenneth

AU - Nyandoto, Paul

AU - Nilsson, Greger

AU - Poikonen-Saksela, Paula

AU - Kataja, Vesa

AU - Bono, Petri

AU - Junnila, Jouni

AU - Lindman, Henrik

PY - 2022/4/1

Y1 - 2022/4/1

KW - DOSE-DENSE CHEMOTHERAPY

KW - PHASE-III TRIAL

KW - NEOADJUVANT CHEMOTHERAPY

KW - CYCLOPHOSPHAMIDE

KW - DOCETAXEL

KW - EPIRUBICIN

KW - THERAPY

KW - METAANALYSIS

KW - ENHANCEMENT

KW - COMBINATION

KW - 3122 Cancers

U2 - 10.1200/JCO.21.02054

DO - 10.1200/JCO.21.02054

M3 - Article

VL - 40

SP - 1051-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 10

ER -